Home

Christine Anna White

CIK 1371859 · last filed 2022-07-07

Christine Anna White is a corporate insider who has filed 46 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MEIP, was dated Jul 7, 2022. Across all open-market trades the lifetime net is +$42.3K, making them a net buyer over the disclosed history. 15 SEC filings were submitted jointly with ARENA PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

46

Lifetime Open-Market Net

$42.3K

Filer Profile

Reported Address
C/O ARENA PHARMACEUTICALS, INC.
SAN DIEGO, CA 92121
Related Filers
ARENA PHARMACEUTICALS INC — 15 joint filings, latest 2017-06-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Lite Strategy, Inc. (MEIP) Delisted Director 750 $3.20 $2.4K $26.1K 13 2022-07-07
ARENA PHARMACEUTICALS INC (ARNA) Delisted Director 8,553 $99.99 $855.2K $16.2K 12 2017-06-14
Lite Strategy, Inc. (MSHL) Delisted Director — — — $0 1 2011-10-24
GENOPTIX INC (GXDX) Delisted Director 0 — — $0 9 2011-03-01
Monogram Biosciences, Inc. (MGRM) Delisted Director — $6.00 — $0 2 2009-01-21

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-07-07 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2021-07-06 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2020-07-07 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2019-09-09 Lite Strategy, Inc. (MEIP) Delisted Buy (P) +15,000 $26.1K EDGAR
2019-07-03 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2018-07-16 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2017-07-10 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2017-06-14 ARENA PHARMACEUTICALS INC (ARNA) Delisted Grant (A) — $0 EDGAR
2016-08-01 Lite Strategy, Inc. (MEIP) Delisted Grant (A) — $0 EDGAR
2016-06-15 ARENA PHARMACEUTICALS INC (ARNA) Delisted Mixed −18,728 -$37.3K EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.